Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy

References

• Stewart B, Wild CP (editors.), International Agency for Research on Cancer, WHO. 2014; World Cancer Report 2014 [Online]. Available from: http://www.thehealthwell.info/node/725845 [Accessed: 24th February 2018].
   Google Scholar
• Sawyers C. Targeted cancer therapy. Nature 2004; 432:294–7.
   PubMed Web of Science ®Google Scholar
• Syn NLX, Yong WP, Goh BC. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review. Expert Opin Drug Metab Toxicol 2016;12:911–22.
   PubMed Web of Science ®Google Scholar
• Ledesma FC, El-Khamisy SF, Zuma MC, et al. A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 2009;461:674–8.
   PubMed Web of Science ®Google Scholar
• Comeaux EQ, van Waardenburg RC. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target. Drug Metab Rev 2014;46:494–507.
   PubMed Web of Science ®Google Scholar
• Laev SS, Salakhutdinov NF, Lavrik OI. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential. Bioorg Med Chem 2016;24:5017–27.
   PubMed Web of Science ®Google Scholar
• Das BB, Dexheimer TS, Maddali K, Pommier Y. Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria. Proc Natl Acad Sci USA 2010;107:19790–5.
   PubMed Web of Science ®Google Scholar
• Yang SW, Burgin AB, Huizenga BN, et al. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci USA 1996;93:11534–9.
   PubMed Web of Science ®Google Scholar
• Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006;6:789–802.
   PubMed Web of Science ®Google Scholar
• Beretta GL, Cossa G, Gatti L, et al. Tyrosyl-DNA Phosphodiesterase 1 Targeting for Modulation of Camptothecin-Based Treatment. Curr Med Chem 2010;17:1500–8.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Barcelo JM, Rao V, et al. Repair of topoisomerase I-mediated DNA damage . Prog Nucleic Acid Res Mol Biol 2006;81:179–229.
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Antony S, Marchand C, et al. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med Chem 2008;8:381–9.
   PubMed Web of Science ®Google Scholar
• Vance JR, Wilson TE. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc Natl Acad Sci USA 2002;99:13669–74.
   PubMed Web of Science ®Google Scholar
• Hartsuiker E, Neale MJ, Carr AM. Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA. Mol Cell 2009;33:117–23.
   PubMed Web of Science ®Google Scholar
• Das BB, Antony S, Gupta S, et al. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. Embo J 2009;28:3667–80.
   PubMed Web of Science ®Google Scholar
• El-Khamisy SF, Katyal S, Patel P, et al. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin. DNA Repair 2009;8:760–6.
   PubMed Web of Science ®Google Scholar
• Hirano R, Interthal H, Huang C, et al. Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation. Embo J 2007;26:4732–43.
   PubMed Web of Science ®Google Scholar
• Barthelmes HU, Habermeyer M, Christensen MO, et al. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II. J Biol Chem 2004;279:55618–25.
   PubMed Web of Science ®Google Scholar
• Nivens MC, Felder T, Galloway AH, et al. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase. Cancer Chemother Pharmacol 2004;53:107–15.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010;17:421–33.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chem Rev 2009;109:3012–43.
   PubMed Web of Science ®Google Scholar
• Efimtseva EV, Kulikova IV, Mikhailov SN. Disaccharide nucleosides as an important group of natural compounds. Mol Biol 2009;43:301–12.
   Web of Science ®Google Scholar
• Efimtseva EV, Mikhailov SN. Disaccharide nucleosides and oligonucleotides on their basis. New tools for the study of enzymes of nucleic acid metabolism. Biochemistry Mosc 2002;67:1136–44.
   PubMed Web of Science ®Google Scholar
• Efimtseva EV, Mikhailov SN. Disaccharide nucleosides. Russian Chemical Reviews 2004;73:401–14.
   Google Scholar
• Efimtseva EV, Kulikova IV, Mikhailov SN. Disaccharide nucleosides and their incorporation into oligonucleotides. Curr Org Chem 2007;11:337–54.
   Web of Science ®Google Scholar
• King AE, Ackley MA, Cass CE, et al. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 2006;27:416–25.
   PubMed Web of Science ®Google Scholar
• Koczor CA, Torres RA, Lewis W. The role of transporters in the toxicity of nucleoside and nucleotide analogs. Expert Opin Drug Metab Toxicol 2012;8:665–76.
   PubMed Web of Science ®Google Scholar
• Efremova AS, Zakharenko AL, Shram SI, et al. Disaccharide pyrimidine nucleosides and their derivatives: a novel group of cell-penetrating inhibitors of poly (ADP-ribose) polymerase 1. Nucleosides. Nucleotides Nucleic Acids 2013;32:510–28.
   PubMed Web of Science ®Google Scholar
• Efremova AS, Shram SI, Drenichev MS, et al. The selective toxic effect of dialdehyde derivatives of pyrimidine nucleosides on human ovarian cancer cells. Biochemistry (Moscow) 2014;8:318–22.
   Google Scholar
• Sherstyuk YV, Zakharenko AL, Kutuzov MM, et al. Synthesis of a series of NAD + analogues, potential inhibitors of PARP 1, using ADP conjugates functionalized at the terminal phosphate group. Russ J Bioorganic Chem 2017;43:76–83.
   Web of Science ®Google Scholar
• Sherstyuk YV, Zakharenko AL, Kutuzov MM, et al. A versatile strategy for the design and synthesis of novel ADP conjugates and their evaluation as potential poly(ADP-ribose) polymerase 1 inhibitors. Mol. Divers 2017;21:101–13.
   PubMed Web of Science ®Google Scholar
• Rodionov AA, Efimtseva EV, Mikhailov SN, et al. Synthesis and properties of O-β-D-ribofuranosyl-(1″-2′)-adenosine-5″-O-phosphate and its derivatives. Nucleosides Nucleotides Nucleic Acids 2000;19:1847–59.
   PubMed Web of Science ®Google Scholar
• Mikhailov S, De Bruyn A, Herdewijn P. Synthesis and properties of some 2'-O- β D-ribofuranosylnucleosides. Nucleosides Nucleotides 1995; 14:481–5.
   Google Scholar
• Efimtseva EV, Shelkunova AA, Mikhailov SN, et al. Synthesis and conformational properties of O-β-D-ribofuranosyl-(1″-2′)-guanosine and (adenosine)-5″-phosphate. Nucleosides Nucleotides Nucleic Acids 2003;22:1109–11.,
   PubMed Web of Science ®Google Scholar
• Efimtseva EV, Shelkunova AA, Mikhailov SN, et al. Synthesis and properties of O-β-D-ribofuranosyl-(1''-2')-guanosine-5''-O-phosphate and its derivatives. Helv Chim Acta 2003;86:504–14.
   Web of Science ®Google Scholar
• Mikhailov SN, Efimtseva EV, Rodionov AA, et al. Synthesis of RNA containing O-beta-D-ribofuranosyl-(1''-2')-adenosine-5''-phosphate and 1-methyladenosine, minor components of tRNA. Chem Biodivers 2005;2:1153–63.
   PubMed Web of Science ®Google Scholar
• Drenichev MS, Kulikova IV, Bobkov GV, et al. A new protocol for selective cleavage of acyl protecting groups in 2′-O-modified 3′, 5′-O-(Tetraisopropyldisiloxane-1, 3-diyl) ribonucleosides. Synthesis 2010; 2010:3827–34.
   Web of Science ®Google Scholar
• Mikhailov SN, Kulikova IV, Nauwelaerts K, et al. Synthesis of 2′-O-α-D-ribofuranosyladenosine, monomeric unit of poly (ADP–ribose). Tetrahedron 2008;64:2871–6.
   Web of Science ®Google Scholar
• Efimtseva EV, Bobkov GV, Mikhailov SN, et al. Oligonucleotides containing disaccharide nucleosides. Helv Chim Acta 2001;84:2387–97.
   Web of Science ®Google Scholar
• Gulyaeva IV, Neuvonen K, Lönnberg H, et al. Effective Anomerisation of 2′‐Deoxyadenosine Derivatives During Disaccharide Nucleoside Synthesis. Nucleosides Nucleotides Nucleic Acids 2004;23:1849–64.
   PubMed Web of Science ®Google Scholar
• Mikhailov SN, De Clercq E, Herdewijn P. Ribosylation of pyrimidine 2′-deoxynucleosides. Nucleosides Nucleotides Nucleic Acids 1996;15:1323–34.
   Web of Science ®Google Scholar
• Efimtseva EV, Shelkunova AA, Mikhailov SN, et al. Synthesis and properties of phosphorylated 3′-O-β-D-Ribofuranosyl-2′-deoxythymidine. Nucleosides Nucleotides Nucleic Acids 2003;22:359–71.
   PubMed Web of Science ®Google Scholar
• Mikhailov SN, Rodionov AA, Efimtseva EV, et al. Formation of trisaccharide nucleosides during disaccharide nucleoside synthesis. European J Org Chem 1998; 1998:2193–9.
   Web of Science ®Google Scholar
• Mikhailov SN, Rodionov AA, Efimtseva EV, et al. Preparation of pyrimidine 5'-O-β-D-ribofuranosyl-nucleosides, and hydrolytic stability of O-D-ribofuranosyl-nucleosides. Carbohydrate Lett 1997;2:321–8.
   Google Scholar
• Lebedeva NA, Rechkunova NI, Lavrik OI. AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1. FEBS Lett 2011;585:683–6.
   PubMed Web of Science ®Google Scholar
• Lebedeva NA, Anarbaev RO, Kupryushkin MS, et al. Design of a new fluorescent oligonucleotide-based assay for a highly specific real-time detection of apurinic/apyrimidinic site cleavage by tyrosyl-DNA phosphodiesterase 1. Bioconjug Chem 2015; 26:2046–53.
   PubMed Web of Science ®Google Scholar
• Zakharenko A, Khomenko T, Zhukova S, et al. Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety. Bioorg Med Chem 2015;23:2044–52.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wientjes MG, Au JL. Evaluation of combination chemotherapy: Integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin Cancer Res 2004;10:7994–8004.
   PubMed Web of Science ®Google Scholar
• Inamdar KV, Pouliot JJ, Zhou T, et al. Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1. J Biol Chem 2002;277:27162–8.
   PubMed Web of Science ®Google Scholar
• Zhou T, Lee JW, Tatavarthi H, et al. Deficiency in 3'-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res 2005;33:289–97.
   PubMed Web of Science ®Google Scholar
• Rechkunova NI, Lebedeva NA, Lavrik OI. Tyrosyl-DNA phosphodiesterase 1 is a new player in repair of apurinic/apyrimidinic sites. Russ J Bioorganic Chem 2015;41:474–80.
   Web of Science ®Google Scholar
• Huang SYN, Murai J, Dalla Rosa I, et al. TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res 2013;41:7793–803.
   PubMed Web of Science ®Google Scholar
• Interthal H, Chen HJ, Champoux JJ. Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages. J Biol Chem 2005;280:36518–28.
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Stephen AG, Fivash MJ, et al. The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase . Nucleic Acids Res 2010;38:2444–52.
   PubMed Web of Science ®Google Scholar
• Rideout MC, Raymond AC, Burgin AB Jr. Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I. Nucleic Acids Res 2004;32:4657–64.
   PubMed Web of Science ®Google Scholar
• Antony S, Marchand C, Stephen AG, et al. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Res 2007;35:4474–84.
   PubMed Web of Science ®Google Scholar
• Sebaugh JL. Guidelines for accurate EC50/IC50 estimation. Pharm Stat 2011;10:128–34.
   PubMed Web of Science ®Google Scholar
• Das BB, Huang SYN, Murai J, et al. PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage. Nucleic Acids Res 2014;42:4435–49.
   PubMed Web of Science ®Google Scholar
• Moor NA, Vasil'eva IA, Anarbaev RO, et al. Quantitative characterization of protein–protein complexes involved in base excision DNA repair. Nucleic Acids Res 2015;43:6009–22.
   PubMed Web of Science ®Google Scholar
• Lebedeva NA, Anarbaev RO, Sukhanova M, et al. Poly (ADP-ribose) polymerase 1 stimulates the AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1. Biosci Rep 2015;35:e00230–10.
   PubMed Web of Science ®Google Scholar
• Zhang YW, Regairaz M, Seiler JA, et al. Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells . Nucleic Acids Res 2011;39:3607–20.
   PubMed Web of Science ®Google Scholar
• Takemura H, Rao VA, Sordet O, et al. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks. J Biol Chem 2006;281:30814–23.
   PubMed Web of Science ®Google Scholar
• Takashima H, Boerkoel CF, John J, et al. Mutation of TDP1, encoding a topoisomerase I–dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 2002;32:267–72.
   PubMed Web of Science ®Google Scholar
• Interthal H, Pouliot JJ, Champoux JJ. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci USA 2001;98:12009–14.
   PubMed Web of Science ®Google Scholar
• Weber G. Rotational Brownian motion and polarization of the fluorescence of solutions. Adv Protein Chem 1953;8:415–59.
   PubMedGoogle Scholar
• Michaelis L, Menten ML. Die kinetik der invertinwirkung. Biochem Z 1913;35:333–69. [English translation by Goody, R. S.; Johnson, K. A. The kinetics of invertase action. Biochem 2011;50:8264–8269].
   Google Scholar
• Kuznetsov NA, Lebedeva NA, Kuznetsova AA, et al. Pre-steady state kinetics of DNA binding and abasic site hydrolysis by tyrosyl-DNA phosphodiesterase 1. J Biomol Struct Dyn 2017;35:2314–27.
   PubMed Web of Science ®Google Scholar
• Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Amer Chem Soc 1934;56:658–66.
   Web of Science ®Google Scholar
• Eadie GS. The inhibition of cholinesterase by physostigmine and prostigmine. J Biol Chem 1942;146:85–93.
   Google Scholar
• Hofstee BHJ. Non-inverted versus inverted plots in enzyme kinetics. Nature 1959;184:1296–8.
   PubMed Web of Science ®Google Scholar
• Eisenthal R, Cornish-Bowden A. The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem J 1974;139:715–20.
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. J Mol Biol 2002;324:917–32.
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. Chem Biol 2003;10:139–47.
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure 2002;10:237–48.
   PubMed Web of Science ®Google Scholar
• Raymond AC, Rideout MC, Staker B, et al. Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues. J Mol Biol 2004;338:895–906.
   PubMed Web of Science ®Google Scholar
• Gajewski S, Comeaux EQ, Jafari N, et al. Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily. J Mol Biol 2012;415:741–58.
   PubMed Web of Science ®Google Scholar